← Leaderboards
Linda Pestano
Prolx Pharmaceuticals Corporation
$973,839
Attributed
$973,839
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$973,839 · 1
By mechanism
R44$973,839 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisAntineoplastic AgentsBaseBiological MarkersBlood FlowCancer CellCancer PatientCancer TherapyCessation Of LifeClinical TrialsClinical Trials, Phase IClinical Trials, Phase IiDrug KineticsDrug MarketGemcitabineHif1a GeneHypoxiaInfusion ProceduresInhibitor/AntagonistIn VivoMagnetic Resonance ImagingMalignant Neoplasm Of PancreasMalignant NeoplasmsAftercare